2-Methyl-penten-2-carbonsaeureamid | 1617-41-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-Methyl-penten-2-carbonsaeureamid
• 英文别名: (2E)-2-methyl-2-pentenamide；trans-2-methyl-pent-2-enoic acid amide；2-methyl-pent-2-enoic acid amide；trans-2-Methyl-pent-2-ensaeure-amid；2-Methyl-pent-2-ensaeure-amid；(E)-2-methylpent-2-enamide
• CAS: 1617-41-0；33034-41-2；128007-43-2
• 化学式: C₆H₁₁NO
• 分子量: 113.159
• InChiKey: PGTISPYIJZXZSE-SNAWJCMRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  8
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-Methyl-penten-2-carbonsaeureamid 在 二异丁基氢化铝 、 三乙胺 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 17.83h， 生成 2-(5-methyl-2-[(1E)-1-methylbut-1-enyl]oxazol-4-yl)ethyl methanesulfonate
  参考文献：
  名称：

  Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: Peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition

  摘要：

  A novel series of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives were synthesized and (S)-2-[(2E,4E)- hexadienoyl]-7-(2-(5-methyl-2-[( 1E)-5-methylhexen-1-yl]oxazol-4-yl]ethoxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (14i) was identified as a potent human peroxisome proliferator-activated receptor gamma (PPAR gamma) selective agonist (EC(50) = 0.03 mu M) and human protein-tyrosine phosphatase 1B (PTP-1B) inhibitor (IC(50) = 1.18 mu M). C(max) after oral administration of 14i at 10 mg/kg was 2.2 mu g/ml (4.5 mu M) in male SD rats. Repeated administration of 14i and rosiglitazone for 14 days dose-dependently decreased plasma glucose levels, ED(50) = 4.3 and 23 mg/kg/day, respectively, in male KK-A(y) mice. In female SD rats, repeated administration of 14i at 12.5-100 mg/kg/day for 28 days had no effect on the hematocrit value (Ht) and red blood cell count (RBC), while rosiglitazone significantly decreased them from 25 mg/kg/day. In conclusion, 14i showed about a fivefold stronger hypoglycemic effect and fourfold or more weaker hemodilution effect than rosiglitazone, indicating that 14i is 20-fold or more safer than rosiglitazone. Compound 14i is a promising candidate for an efficacious and safe anti-diabetic drug targeting PPAR gamma and PTP-1B. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.11.035
• 作为产物：
  描述：

  (E)-2-methyl-2-pentenoyl chloride 在 氨 作用下， 以 水 为溶剂， 反应 2.0h， 以9.53 g的产率得到2-Methyl-penten-2-carbonsaeureamid
  参考文献：
  名称：

  Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: Peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition

  摘要：

  A novel series of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives were synthesized and (S)-2-[(2E,4E)- hexadienoyl]-7-(2-(5-methyl-2-[( 1E)-5-methylhexen-1-yl]oxazol-4-yl]ethoxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (14i) was identified as a potent human peroxisome proliferator-activated receptor gamma (PPAR gamma) selective agonist (EC(50) = 0.03 mu M) and human protein-tyrosine phosphatase 1B (PTP-1B) inhibitor (IC(50) = 1.18 mu M). C(max) after oral administration of 14i at 10 mg/kg was 2.2 mu g/ml (4.5 mu M) in male SD rats. Repeated administration of 14i and rosiglitazone for 14 days dose-dependently decreased plasma glucose levels, ED(50) = 4.3 and 23 mg/kg/day, respectively, in male KK-A(y) mice. In female SD rats, repeated administration of 14i at 12.5-100 mg/kg/day for 28 days had no effect on the hematocrit value (Ht) and red blood cell count (RBC), while rosiglitazone significantly decreased them from 25 mg/kg/day. In conclusion, 14i showed about a fivefold stronger hypoglycemic effect and fourfold or more weaker hemodilution effect than rosiglitazone, indicating that 14i is 20-fold or more safer than rosiglitazone. Compound 14i is a promising candidate for an efficacious and safe anti-diabetic drug targeting PPAR gamma and PTP-1B. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.11.035

文献信息

• [EN] LIGHT HARVESTING ARRAY<br/>[FR] RÉSEAU COLLECTEUR DE LUMIÈRE
  申请人：FLUROSOL IND PTY LTD

  公开号：WO2015024064A1

  公开（公告）日：2015-02-26

  The invention relates to a light harvesting array or dye comprising an acceptor linked to a donor, wherein at least one of the acceptor or the donor is an oligomeric unit comprising a first optionally substituted rylene linked via a linker group to a second optionally substituted rylene, the first optionally substituted rylene is linked to the acceptor or the donor and the second optionally substituted rylene is capable of energy transfer to at least one of the first optionally substituted rylene, the acceptor or the donor. The invention also relates to compounds which may be used as light harvesting arrays, methods for their manufacture, and devices and materials comprising the light harvesting array or dye, for example, chromophoric materials, light guides, photobioreactors, photoluminescent algae systems, photodetectors, photovoltaic devices and luminescent/fluorescent solar concentrators.

  该发明涉及一种光收集阵列或染料，包括一个与给体相连的受体，其中受体或给体中至少有一个是包含第一可选择取代的芳香烃单元通过连接基团连接到第二可选择取代的芳香烃的寡聚单元，第一可选择取代的芳香烃与受体或给体相连，第二可选择取代的芳香烃能够将能量传递至第一可选择取代的芳香烃、受体或给体中的至少一个。该发明还涉及可用作光收集阵列的化合物，其制造方法，以及包括光收集阵列或染料的设备和材料，例如，色素材料、光导管、光生物反应器、光致发光藻类系统、光探测器、光伏器件和发光/荧光太阳能聚光器。
• PHENALENE-1-ONE-CONTAINING PHOTOSENSITIZER COMPOSITION, PHENALENE-1-ONE COMPOUND AND THE USE THEREOF
  申请人：TriOptoTec GmbH

  公开号：US20200087259A1

  公开（公告）日：2020-03-19

  A phenalene-1-one compound, a photosensitizer composition including the phenalene-1-one compound, an article including the phenalene-1-one compound and/or photosensitizer composition and the use thereof.

  一种苯并吲哚酮化合物，一种包括该苯并吲哚酮化合物的光敏剂组合物，一种包括该苯并吲哚酮化合物和/或光敏剂组合物的物品以及其用途。
• [EN] "COMPOUNDS AS POTENTIAL DYE MOLECULES"<br/>[FR] COMPOSÉS UTILISÉS EN TANT QUE MOLÉCULES DE COLORANT POTENTIELLES
  申请人：LLEAF PTY LTD

  公开号：WO2019028508A1

  公开（公告）日：2019-02-14

  Disclosed herein are a series of compounds based on Formula (I). These compounds comprise perylene core which has been extended with optionally functionalised imidazoles at the 3,4;9,10 positions. The compounds of Formula (I) can be functionalised at two positions on the perylene core, such as the 1,6 or 1,7 positions. Also disclosed herein are compositions comprising said compounds, methods of forming said compounds and potential applications of said compounds, such as applying the compounds as a dye whose absorbance and fluorescence spectrum are red-shifted.

  本文披露了一系列基于化学式(I)的化合物。这些化合物包括带有可选择功能化的咪唑基团的苝芯，该苝芯在3,4;9,10位置进行了扩展。化学式(I)的化合物可以在苝芯的两个位置进行功能化，例如1,6或1,7位置。本文还披露了包含所述化合物的组合物、形成所述化合物的方法以及所述化合物的潜在应用，例如将化合物应用为吸收和荧光光谱向红移的染料。
• [EN] PHOTOPERIODIC CONTROL OF PHYTOCHROME WITH MATERIALS<br/>[FR] CONTRÔLE PHOTOPÉRIODIQUE DE PHYTOCHROME AVEC DES MATÉRIAUX
  申请人：LLEAF PTY LTD

  公开号：WO2020163917A1

  公开（公告）日：2020-08-20

  Disclosed herein are articles and devices, such as photo-selective films, which may be used to influence the growth of photosynthetic organisms. These article and devices may comprise one or more compounds of Formula (I) and/or Formula (II), along with one or more optional auxiliary dyes. Methods of controlling the growth of plants and for the manufacture of said articles and devices are also disclosed herein.

  本文披露了一些文章和设备，例如光选择性薄膜，可用于影响光合生物的生长。这些文章和设备可能包括一个或多个Formula（I）和/或Formula（II）的化合物，以及一个或多个可选的辅助染料。本文还披露了控制植物生长的方法以及用于制造上述文章和设备的方法。
• MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF
  申请人：BOSTIK SA

  公开号：US20210179576A1

  公开（公告）日：2021-06-17

  The invention relates to a monoethylenically unsaturated monomer of formula (I), and to the use thereof for producing a polymer. The invention also relates to the polymer obtained by polymerising said monomer, and to the use thereof in a composition for producing coatings.

  该发明涉及一种具有化学式(I)的单乙烯不饱和单体，以及其用于生产聚合物的用途。该发明还涉及通过聚合所述单体而获得的聚合物，以及其在用于生产涂层的组合物中的用途。